scholarly article | Q13442814 |
P2093 | author name string | Koch U | |
Zander AR | |||
Schirmer L | |||
Mehnert A | |||
Scherwath A | |||
Schleimer B | |||
Schulz-Kindermann F | |||
P2860 | cites work | The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Q29615701 |
Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. | Q33183929 | ||
Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: a comparative study. | Q33214552 | ||
'Chemobrain' in breast carcinoma?: a prologue | Q33980187 | ||
Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature | Q35635738 | ||
Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target | Q35776955 | ||
Prospective evaluation of neurological complications after allogeneic bone marrow transplantation | Q43994969 | ||
Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients | Q44114761 | ||
Characteristics and correlates of cognitive functioning following bone marrow transplantation | Q44458858 | ||
Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant | Q44976801 | ||
A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function | Q46784141 | ||
Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation | Q48470542 | ||
Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study | Q48769871 | ||
Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. | Q51099382 | ||
Psychologic and neuropsychologic impact of autologous bone marrow transplantation. | Q51114762 | ||
Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. | Q51135034 | ||
Neuropsychologic impairment in adult bone marrow transplant candidates | Q52070277 | ||
The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy | Q56989841 | ||
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 | ||
Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects | Q81631400 | ||
Promotion of neurogenesis by human stem cells in high-risk breast cancer survivals after stem-cell supported high-dose therapy | Q83181266 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 789-799 | |
P577 | publication date | 2007-04-09 | |
P1433 | published in | Bone Marrow Transplantation | Q4941523 |
P1476 | title | Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies. | |
P478 | volume | 39 |
Q41186091 | A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients |
Q27013566 | A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation |
Q41923053 | Central nervous system complications after allogeneic hematopoietic stem cell transplantation |
Q35815463 | Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation |
Q57154398 | Cognitive Function and Quality of Life in Vorinostat-Treated Patients Following Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplant |
Q47373380 | Cognitive function and its relationship to other psychosocial factors in lymphoma survivors |
Q50786894 | Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study. |
Q37362483 | Consistency and construct validity of the Activity Card Sort (modified) in measuring activity resumption after stem cell transplantation. |
Q36578771 | Developing a Risk Prediction Model for Long-Term Physical and Psychological Functioning after Hematopoietic Cell Transplantation |
Q48453012 | Factors associated with changes in quality of life in patients undergoing allogeneic haematopoietic stem cell transplantation |
Q33606151 | Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention |
Q48798780 | Health-related quality of life in haematopoietic stem cell transplant survivors: a qualitative study on the role of psychosocial variables and response shifts |
Q48324199 | Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT. |
Q37359876 | Mental status changes after hematopoietic stem cell transplantation |
Q41995096 | Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review From the Late Effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT. |
Q48222982 | Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. |
Q37901973 | Neurological complications of transplantation |
Q36746364 | Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. |
Q33949546 | Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies |
Q91345168 | Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation |
Q41604163 | Prospective assessment of white matter integrity in adult stem cell transplant recipients |
Q35023468 | Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years |
Q38203303 | Psychiatric and psychosocial challenges in patients undergoing haematopoietic stem cell transplants |
Q41333675 | Quality of Life and Psychopathology in Adults Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) in Childhood: A Qualitative and Quantitative Analysis. |
Q37262503 | Quality of life after allogeneic hematopoietic cell transplantation |
Q37878252 | Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30. |
Q34729742 | Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation |
Q33914006 | The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). |
Q56979005 | What Do Transplant Physicians Think About Palliative Care? A National Survey Study |
Search more.